Neil Herskowitz - 21 Jul 2022 Form 4 Insider Report for Journey Medical Corp (DERM)

Role
Director
Signature
/s/ Ramsey Alloush, attorney-in-fact
Issuer symbol
DERM
Transactions as of
21 Jul 2022
Net transactions value
$0
Form type
4
Filing time
25 Jul 2022, 09:36:51 UTC
Previous filing
24 Jun 2022
Next filing
03 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DERM Common Stock, par value $0.0001 per share Award $0 +14,245 +47% $0.000000 44,245 21 Jul 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 21, 2022, the reporting person was granted 14,245 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 21, 2023.
F2 Includes 34,245 restricted stock units, 14,245 of which will vest over various time periods as set forth in footnote 1, and 20,000 of which will vest in increments as follows: (1) 10,000 units on July 1, 2023, and (2) 10,000 units on July 1, 2024.

Remarks:

Exhibit 24 - Power of Attorney